Adhere+ Raises $2.45M Backed by Optimus Healthcare to Scale Remote Therapeutic Monitoring Platform
Adhere+, a healthcare technology company focused on Remote Therapeutic Monitoring (RTM) and chronic care compliance systems, has raised approximately $2.45 million in disclosed early-stage funding as it scales its platform for patient engagement, clinical analytics, and reimbursement-enabled care delivery.
The company’s funding has been raised across multiple early financing events, including seed-stage capital used to build and commercialize its RTM infrastructure. According to publicly available startup intelligence, Adhere+ has completed small-scale fundraising activity since its founding in 2020, though it remains largely early-stage in structure and capital base.
Public records indicate that Adhere+ has received backing from Optimus Healthcare, which is the only publicly disclosed institutional investor associated with the company’s funding history. No additional venture capital firms or angel syndicates have been formally confirmed in available filings or press disclosures.
Adhere+ operates a clinical Remote Therapeutic Monitoring platform designed to bridge the gap between patient visits by collecting continuous electronic patient-reported outcomes (ePROs). These inputs are processed into actionable clinical insights that help providers track adherence, symptoms, and treatment progress in real time. The system is aligned with CMS reimbursement frameworks and AMA CPT codes that allow providers to bill for RTM services, making it both a clinical and revenue-generating infrastructure tool for healthcare organizations.
The platform is built to automate documentation, reduce administrative burden, and improve care continuity across chronic conditions such as pain management, obesity, and substance use disorders. By digitizing patient engagement workflows, Adhere+ enables providers to maintain ongoing communication without requiring in-person visits, supporting the broader shift toward value-based care.
The company reports large-scale engagement across its platform, including more than 1 million annual electronic patient-reported outcomes and hundreds of thousands of monthly patient interactions. These metrics are used to generate real-world evidence datasets that support clinical decision-making and payer reimbursement alignment.
In addition to clinical workflow automation, Adhere+ integrates compliance and billing tools that map patient interactions directly to reimbursable CPT codes. This capability is particularly important in the expanding Remote Therapeutic Monitoring market, where providers increasingly rely on digital platforms to maintain financial sustainability while improving patient outcomes.
Founded by a team with experience in healthcare operations, medical device commercialization, and digital health systems, Adhere+ has positioned itself at the intersection of clinical care and healthcare SaaS infrastructure. Its leadership includes executives with prior experience scaling medtech and pharmaceutical ventures, which has helped guide its early commercialization strategy.
The company’s growth has been supported by its participation in healthcare innovation ecosystems and partnerships with clinical networks deploying RTM programs across multiple specialties. While its investor base remains limited compared to larger digital health companies, its focus on reimbursement-driven adoption has enabled early traction without heavy reliance on large institutional venture capital rounds.
Recent industry positioning suggests Adhere+ is preparing for expanded scale, particularly as regulatory frameworks increasingly support remote care delivery models. Telehealth and RTM reimbursement policies have strengthened in recent years, creating a favorable environment for companies like Adhere+ that provide compliance-ready monitoring infrastructure.
With backing from Optimus Healthcare and continued expansion of its clinical adoption footprint, Adhere+ is now focused on scaling its platform across additional specialties, improving patient engagement automation, and expanding integration with electronic health record systems.
As the Remote Therapeutic Monitoring sector continues to grow, Adhere+ is positioning itself as a data-driven infrastructure provider for chronic care management, combining patient engagement, compliance automation, and reimbursement optimization into a single platform designed for modern healthcare systems.
